Universe Pharmaceuticals INC Schedule 13G passive stakes

Star Voyage International Limited and Xuncheng Chen report a combined beneficial ownership of 9.94% in Universe Pharmaceuticals INC's Class A ordinary shares.

August Luck Global Limited and Xuefeng Li now collectively beneficially own 9.29% of Universe Pharmaceuticals INC's Class A ordinary shares.

Meridian Prosperous Limited and Shanshan Lu have filed a Schedule 13G, reporting beneficial ownership of 498,922 Class A ordinary shares, representing 9.96% of Universe Pharmaceuticals INC.

Horizon Ridge Limited and Shan Xie have jointly filed a Schedule 13G, reporting beneficial ownership of 9.97% of Universe Pharmaceuticals INC's Class A ordinary shares.

Origin Force Intelligence Limited and Piao Ye have entered into a joint filing agreement to report beneficial ownership of Universe Pharmaceuticals INC Class A ordinary shares.

Clever Way Global Limited and Lu Yang have jointly filed a Schedule 13G, reporting beneficial ownership of 9.96% of Universe Pharmaceuticals INC's Class A ordinary shares.

Orbis BioCapital Limited and Chunhua Zheng have jointly reported beneficial ownership of 9.98% of Universe Pharmaceuticals INC's Class A ordinary shares.

A significant stakeholder, Whitmore Limited and its controller Chengming Tang, has reported beneficial ownership of 9.97% of Universe Pharmaceuticals' Class A ordinary shares.

Sabby Management, Sabby Volatility Warrant Master Fund, and Hal Mintz have jointly disclosed a passive 4.9% beneficial ownership in Universe Pharmaceuticals INC's Ordinary Shares as of December 31, 2025.

Anson Funds Management LP and its affiliated entities, including Anson Management GP LLC, Anson Advisors Inc., and key individuals Tony Moore, Amin Nathoo, and Moez Kassam, have disclosed a collective beneficial ownership of 0.98% of Universe Pharmaceuticals, Inc.'s Ordinary Shares.

Anson Funds Management LP and its affiliates have reported a 9.9% beneficial ownership stake in Universe Pharmaceuticals, Inc., held for ordinary course of business purposes.

Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have jointly disclosed a 9.9% beneficial ownership stake in Universe Pharmaceuticals INC, held for passive investment purposes.